Market accessOfficial

IGJ lifts restrictions on Jiaxing Tianhe BAL flush syringes made from 2026 onwards

🇳🇱 IGJ · Thu 19 Nov 2026

Dutch inspectorate says use, distribution and quarantine rules under FSCA TH-FSCA-2026001 no longer apply to 10 ml syringe batches produced on or after 1 January 2026, subject to date verification.

The Dutch healthcare inspectorate IGJ has announced that the restrictions on use and distribution, and the quarantine obligations, set out in field safety corrective action TH-FSCA-2026001 are being lifted for part of the affected stock. The product is the BAL Flush Syringe SS, 10 ml, made by Jiaxing Tianhe Pharmaceutical Co., Ltd.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: IGJ ↗

Article written by VigiEye from the official source (IGJ). AI-assisted; check the source before acting.